Margaret Henry
Corporate Secretary at ADAPTIMMUNE THERAPEUTICS PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Helena Tayton-Martin | M | 57 |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | 16 years |
| Adrian Rawcliffe | M | 52 | 9 years | |
| Gavin Wood | M | 54 |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | 4 years |
| David Mott | M | 58 | 10 years | |
| Elliot Norry | M | 61 | 9 years | |
| Ali Behbahani | M | 45 | 10 years | |
| Joanna Brewer | M | 47 | 15 years | |
| John Furey | M | 59 | 6 years | |
| Lawrence Alleva | M | 74 | 9 years | |
| Juli P. Miller | M | - | 8 years | |
| Sharp Kerry | F | - | 9 years | |
| Phil Bassett | M | - | - | |
| John Lunger | M | 55 | 7 years | |
| William Bertrand | M | 59 | 7 years | |
| Priti Hegde | M | 52 | 1 years | |
| Adrian George Rawcliffe | M | - |
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | - |
| Kristen Hege | M | 60 | 1 years | |
| Garry Menzel | M | 59 | 1 years | |
| Andrew Allen | M | 57 | 1 years | |
| Dana Lynch | F | - | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 20 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Margaret Henry
- Personal Network
